top of page
DANIEL DELITTO, MD, PhD, FACS
Innovation
Fibroblast-mediated Suppression
of T Cell Function
in Pancreatic Cancer
We have shown that fibroblasts can profoundly suppress T cell function, preventing the immune system from killing cancer cells (Delitto et al., Cancer Res, 2017).
We are now developing therapies to dismantle this protective effect of fibroblasts, allowing the immune system to target and eliminate pancreatic cancer cells.
Funding
Funding
bottom of page